University of Pennsylvania: Novel Drug Shows Early Promise in Treating Multiple Myeloma
December 12, 2022
December 12, 2022
NEW ORLEANS, Louisiana, Dec. 12 (TNSres) -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania's Abramson Cancer Center at the 2022 American Society of Hematology (ASH) Annual Meeting (Abstract 565).
Patients i . . .
A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania's Abramson Cancer Center at the 2022 American Society of Hematology (ASH) Annual Meeting (Abstract 565).
Patients i . . .